• IMA sites
  • IMAJ services
  • IMA journals
  • Follow us
  • Alternate Text Alternate Text
עמוד בית
Tue, 28.05.24

CASE COMMUNICATIONS

IMAJ | volume 25

Journal 12, December 2023
pages: 828-829

A Severe Acute Kidney Injury Following Zoledronic Acid Therapy Leading to Chronic Hemodialysis Treatment: A Case Report

1 Department of Internal Medicine E, Meir Medical Center, Kfar Saba, Israel 2 Department of Nephrology, Meir Medical Center, Kfar Saba, Israel 3 Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

Summary

Higher potency bisphosphonates, typically intravenous formulations, are given at lower doses for postmenopausal women. The treatment has improved compliance compared to daily oral therapy. Since bisphosphonates are exclusively excreted via the kidneys, intravenous formulation has been associated with deterioration of renal function, specifically in the setting of preexisting renal disease or concomitant use of nephrotoxic agents [1].

Legal Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal or medical advice on any matter.
The IMA is not responsible for and expressly disclaims liability for damages of any kind arising from the use of or reliance on information contained within the site.
© All rights to information on this site are reserved and are the property of the Israeli Medical Association. Privacy policy

2 Twin Towers, 35 Jabotinsky, POB 4292, Ramat Gan 5251108 Israel